Fate Therapeutics Inc Shares Close the Day 10.2% Lower - Daily Wrap

The company saw its shares close the day 10.2% lower than yesterday, with trading volume higher than its 30 day average.

Jun 13, 2022 by Kwhen Finance Editors

Fate Therapeutics Inc Shares Close the Day 10.2% Lower - Daily Wrap
Fate Therapeutics Inc (FATE) shares closed today 10.2% lower than it did at the end of yesterday. The stock is currently down 66.1% year-to-date, down 77.9% over the past 12 months, and up 558.1% over the past five years. Today, the Dow Jones Industrial Average fell 2.8%, and the S&P 500 fell 3.8%.

Trading Activity

  • Shares traded as high as $25.10 and as low as $19.62 this week.
  • Shares closed 81.8% below its 52-week high and 9.4% below its 52-week low.
  • Trading volume this week was 19.3% higher than the 10-day average and 37.3% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 2.1.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Fate Therapeutics Inc-10.2-66.1-77.9-80.8-4.7
Dow Jones Industrial Average-2.8-12.8-7.3-16.20.4
S&P 500 Index-3.8-17.7-6.9-20.6-0.1
Health Care-1.7-12.4-1.6-14.8-0.9

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 269.4%
  • The company's stock price performance over the past 12 months lags the peer average by 269.8%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Fate Therapeutics IncFATE-8.2-66.1-77.9-80.8-4.7
Peer AvgN/A28.9-17.9-21.1-32.311.5
Becton, Dickinson And Co.BDX38.92.36.7-11.47.8
Neurocrine Biosciences, Inc.NBIX126.210.7-4.4-14.328.7
Sarepta Therapeutics IncSRPT-17.0-23.2-19.6-34.18.9
PTC Therapeutics IncPTCT-3.7-32.7-37.6-43.4-0.4
Avidity Biosciences IncRNA0-46.6-50.5-58.112.5

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: